(Q51917360)

English

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.

scientific article published in June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

quality of life

1 reference

based on heuristic

inferred from title

Christopher Griffiths

11

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

author name string

Reich K

1

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Nestle FO

2

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Papp K

3

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Ortonne JP

4

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Wu Y

5

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Bala M

6

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Evans R

7

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Guzzo C

8

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Li S

9

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Dooley LT

10

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

language of work or name

0 references

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

154

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

6

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

1161-1168

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Quality-of-life issues in psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Psoriasis causes as much disability as other major medical diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

[Skin disease and sexuality. An empirical study of sex behavior or patients with psoriasis vulgaris and neurodermatitis in comparison with skin-healthy probands]

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Psoriasis and sex: a study of moderately to severely affected patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Biological therapies in the systemic management of psoriasis: International Consensus Conference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Translating the science of quality of life into practice: What do dermatology life quality index scores mean?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07237.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2006.07237.X

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/16704649

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51917360&oldid=1699866106"